Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
|
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [21] Healthcare resource utilization and costs associated with postpartum depression among commercially insured households
    Epperson, C. Neill
    Huang, Ming-Yi
    Cook, Keziah
    Gupta, Deepshekhar
    Chawla, Anita
    Greenberg, Paul E.
    Eldar-Lissai, Adi
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1707 - 1716
  • [22] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED STATES
    Cameron, A.
    Barrett, M.
    Malik, A.
    Woodford, C.
    Alpert, N.
    Vuong, V.
    Boers, E.
    Kaye, L.
    Sterling, K. L.
    VALUE IN HEALTH, 2022, 25 (12) : S176 - S176
  • [23] THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES
    Estes, S.
    Soliman, A. M.
    Zivkovic, M.
    Zhu, X.
    Chopra, D.
    VALUE IN HEALTH, 2020, 23 : S239 - S239
  • [24] Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
    Kabadi, Shaum M.
    Near, Aimee
    Wada, Keiko
    Burudpakdee, Chakkarin
    CANCER MEDICINE, 2019, 8 (17): : 7174 - 7185
  • [25] Healthcare Resource Utilization Among Commercially Insured Clobazam-Treated Patients with Lennox-Gastaut Syndrome
    Francois, Clement
    Stern, John
    Ogbonnaya, Augustina
    Lokhandwala, Tasneem
    Landsman-Blumberg, Pamela
    Duhig, Amy
    Shen, Vivienne
    NEUROLOGY, 2016, 86
  • [26] Healthcare Resource Utilization Among Commercially Insured Clobazam-Treated Patients with Lennox-Gastaut Syndrome
    Francois, Clement
    Stern, John
    Ogbonnaya, Augustina
    Lokhandwala, Tasneem
    Landsman-Blumberg, Pamela
    Duhig, Amy
    Shen, Vivienne
    NEUROLOGY, 2016, 86
  • [27] Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
    Wendy L. St. Peter
    Haifeng Guo
    Shaum Kabadi
    David T. Gilbertson
    Yi Peng
    Trudy Pendergraft
    Suying Li
    BMC Nephrology, 19
  • [28] Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
    St Peter, Wendy L.
    Guo, Haifeng
    Kabadi, Shaum
    Gilbertson, David T.
    Peng, Yi
    Pendergraft, Trudy
    Li, Suying
    BMC NEPHROLOGY, 2018, 19
  • [29] The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States
    Wallace, Zachary S.
    Miles, Gandarvaka
    Smolkina, Ekaterina
    Petruski-Ivleva, Natalia
    Madziva, Duane
    Guzzo, Krishan
    Cook, Claire
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John H.
    Choi, Hyon K.
    RHEUMATOLOGY, 2024, 63 (09) : 2457 - 2466
  • [30] Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women
    Morgan, Daniel M.
    Kamdar, Neil S.
    Swenson, Carolyn W.
    Kobernik, Emily K.
    Sammarco, Anne G.
    Nallamothu, Brahmajee
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (04) : 425.e1 - 425.e18